Press Release Press Release List


Journal Citation Reportstm 2021 - A Significant Increase in Impact Factor Ratings For Bentham Science Journals PRESS RELEASE DATE : 07-July-2021

Clarivate has recently published the latest edition of Journal Citation ReportsTM providing information for the category ranking and Impact Factor ratings of indexed journals in 2020. Bentham Science journals have performed well and received good Impact Factor rankings this year. 35 out of our 40 ranked journals have secured a higher Impact Factor, while 5 journals have, more or less, maintained their ratings.

Current Neuropharmacology has proved to be the most impactful title from our catalog again over the last year in terms of publishing quality research that has been readily cited by the researchers worldwide. Its Impact Factor has increased to 7.363 from 4.668 In the previous period.

Other highlights in the report include Current Gene Therapy (Impact Factor 2020: 4.391) and Recent Patents on Anti-Cancer Drug Discovery (Impact Factor 2020: 4.169), which have received an appreciable increase in Impact Factors.

Bentham Science congratulates all of its contributors and looks forward to raising the bar on publishing impactful research for the benefit of the global scientific community.

Here is the list of all of Bentham’s Impact Factor journals.

BSP JOURNALS20192020
CURRENT NEUROPHARMACOLOGY4.6687.363
CURRENT MEDICINAL CHEMISTRY4.1844.53
CURRENT GENE THERAPY2.4314.391
CNS NEUROLOGICAL DISORDERS -DRUG TARGETS04.388
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY2.614.169
MINI-REVIEWS IN MEDICINAL CHEMISTRY2.7333.862
CURRENT STEM CELL RESEARCH & THERAPY2.6143.828
CURRENT DRUG METABOLISM2.963.731
CURRENT BIOINFORMATICS2.0683.543
CURRENT ALZHEIMER RESEARCH3.0473.498
CURRENT DRUG TARGETS2.6323.465
CURRENT CANCER DRUG TARGETS2.9123.428
CURRENT MOLECULAR PHARMACOLOGY3.2833.339
CURRENT TOPICS IN MEDICINAL CHEMISTRY3.2183.295
CURRENT PROTEIN & PEPTIDE SCIENCE2.523.272
CURRENT PHARMEUTICAL DESIGN2.2083.116
ENDOCRINE, METABOLIC & IMMUNE DISORDERS - DRUG TARGETS1.9732.895
CURRENT PHARMACEUTICAL BIOTECHNOLOGY2.0972.837
MEDICINAL CHEMISTRY2.5772.745
CURRENT VASCULAR PHARMACOLOGY2.6722.719
CURRENT DRUG DELIVERY1.5822.565
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY2.0492.505
MINI-REVIEWS IN ORGANIC CHEMISTRY1.8242.495
CURRENT GENOMICS2.632.236
CURRENT MOLECULAR MEDICINE1.62.222
CURRENT ORGANIC CHEMISTRY1.9332.18
CURRENT NEUROVASCULAR RESEASRCH1.6491.99
CURRENT ORGANIC SYNTHESIS1.9831.975
RECENT PATENTS ON NANOTECHNOLOGY0.9771.952
CURRENT ANALYTICAL CHEMISTRY1.3651.892
PROTEIN & PEPTIDE LETTERS1.1561.89
CURRENT NANOSCIENCE1.8361.824
CURRENT COMPUTER-AIDED DRUG DESIGN0.9351.606
CURRENT HIV RESEASRCH0.8021.581
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING1.1951.339
LETTERS IN DRUG DESIGN & DISCOVERY1.1691.15
CURRENT PHARMACEUTICAL ANALYSIS0.9230.89
LETTERS IN ORGANIC CHEMISTRY0.7790.867
CURRENT MEDICAL IMAGING0.8120.858
CURRENT PROTEOMICS0.680.837